Tourette’s and related tic disorders are relatively common and often impairing conditions. While pharmacotherapy has historically been considered the first-line (and only) active treatment for tics, medication use in children has been limited by safety and tolerability concerns. Over the past two decades behavioral treatments, most notably, the Comprehensive Behavioral Intervention for Tics (CBIT), have demonstrated efficacy and tolerability for tics in youth and adults, leading to designation as a first-line treatment, when available, for treating tics by the American Academy of Neurology and European and Canadian medical academies. This presentation will review the clinical aspects of Tourette’s and other tic disorders most relevant for treatment and describe the theoretical underpinings, implementation, benefits, and long-term outcomes of CBIT with reference to other treatment modalities. Core treatment elements will be demonstrated to illustrate their role in treatment. Following completion of the presentation, attendees should be able to describe the core components of this treatment.